APA (7th ed.) Citation

LC, L., M, F., W, L., AJ, B., B, G., A, C., . . . PE, L. (2025). The sodium/glucose cotransporter 2 inhibitor Empagliflozin inhibits long QT 3 late sodium currents in a mutation specific manner. Journal of molecular and cellular cardiology, 198, 99. https://doi.org/10.1016/j.yjmcc.2024.11.014

Chicago Style (17th ed.) Citation

LC, Lunsonga, Fatehi M, Long W, Barr AJ, Gruber B, Chattopadhyay A, Barakat K, Edwards AG, and Light PE. "The Sodium/glucose Cotransporter 2 Inhibitor Empagliflozin Inhibits Long QT 3 Late Sodium Currents in a Mutation Specific Manner." Journal of Molecular and Cellular Cardiology 198 (2025): 99. https://doi.org/10.1016/j.yjmcc.2024.11.014.

MLA (9th ed.) Citation

LC, Lunsonga, et al. "The Sodium/glucose Cotransporter 2 Inhibitor Empagliflozin Inhibits Long QT 3 Late Sodium Currents in a Mutation Specific Manner." Journal of Molecular and Cellular Cardiology, vol. 198, 2025, p. 99, https://doi.org/10.1016/j.yjmcc.2024.11.014.